financetom
Business
financetom
/
Business
/
Oil Trading at a Five-Week High as U.S.-China Trade Talks Continue
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Oil Trading at a Five-Week High as U.S.-China Trade Talks Continue
Jun 10, 2025 6:12 AM

08:41 AM EDT, 06/10/2025 (MT Newswires) -- Oil futures rose for a fourth day early on Tuesday, climbing to a five-week high on hopes talks between China and the United States will bring an end to the trade war between the two largest economies that has disrupted global trade wars.

West Texas Intermediate crude oil was last seen up US$0.38 to US$65.67 per barrel, the highest since April 3, while August Brent crude was up US$0.42 to US$67.46.

The rise comes as talks between the United States and China in London enter their second day, with the market hoping a deal will emerge that will end the tariff battle between the pair and boost a global economy that is weakening amid the trade wars launched in April by U.S. President Donald Trump.

The prospect of a deal between the two countries is raising hopes for a return to growth that will support oil demand even as supply from OPEC+ is on the rise with Saudi Arabia looking to regain market share lost to U.S. shale producers.

"One must admire the optimism of investors. The Sino/US trade talks enter a second day and instead of being seen as them being a touch sticky, markets across the gamut of investment are starting to price a successful outcome. Yes, hope is whipped by the US Administration with the likes of the Commerce Secretary, Howard Lutnick, observing initial discussions had been "fruitful" which was endorsed by his President back in Washington claiming, "we are doing well with China," PVM Oil Associates noted.

Prices have also been supported by continuing shortfalls in Canadian supply, with oil-sands producers shutting in nearly 300,000 barrels per day of supply due to wildfires in northern Alberta.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
New Found Gold Taps New CFO, COO, Independent Board Director
New Found Gold Taps New CFO, COO, Independent Board Director
Sep 15, 2025
07:34 AM EDT, 09/15/2025 (MT Newswires) -- New Found Gold ( NFGC ) said Monday that it has named Hashim Ahmed chief financial officer and Robert Assabgui chief operating officer. The company also named Andrew Furey as an independent director of the company's board. The three appointments are effective immediately. Ahmed joins New Found Gold ( NFGC ) from Mandalay...
Monte Rosa Therapeutics Partners With Novartis on Immune Disease Degraders; Shares Rise Pre-Bell
Monte Rosa Therapeutics Partners With Novartis on Immune Disease Degraders; Shares Rise Pre-Bell
Sep 15, 2025
07:34 AM EDT, 09/15/2025 (MT Newswires) -- Monte Rosa Therapeutics ( GLUE ) said Monday it has entered into an agreement to collaborate with Novartis ( NVS ) to develop novel degraders for immune-mediated diseases. The company said it will receive an upfront payment of $120.0 million. Novartis ( NVS ) also receives options to license two programs from Monte...
BlackRock Converts 2 Mutual Funds Into Exchange-Traded Funds
BlackRock Converts 2 Mutual Funds Into Exchange-Traded Funds
Sep 15, 2025
07:33 AM EDT, 09/15/2025 (MT Newswires) -- BlackRock ( BLK ) said Monday it converted two funds from its Global Allocation suite into active exchange-traded funds. The GA Dynamic Equity Fund is now the iShares Dynamic Equity Active ETF (BDYN), while the GA Disciplined Volatility Equity Fund is now iShares Disciplined Volatility Equity Active ETF (BDVL). Both ETFs retain the...
aTyr Pharma's lung disease drug misses main goal in late-stage trial
aTyr Pharma's lung disease drug misses main goal in late-stage trial
Sep 15, 2025
Sept 15 (Reuters) - aTyr Pharma ( ATYR ) said on Monday its experimental drug did not meet the main goal in a late-stage study in patients with a type of lung disease known as pulmonary sarcoidosis. ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved